A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)

NCT07794761 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
180
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer